SMTL ID : 4l8m.1

Human p38 MAP kinase in complex with a Dibenzoxepinone

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

monomer

Ligands

2 x BOG: octyl beta-D-glucopyranoside(Non-covalent)

BOG.1: 14 residues within 4Å: Chain A: R.70, L.74, M.78, V.83, I.84, I.141, I.146, I.147, H.148, R.149, D.168, Q.325, E.328 Ligands: F46.3 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:V.83, A:I.84, A:I.141, A:I.146, A:D.168 Hydrogen bonds: A:Q.325 Water bridges: A:R.149, A:R.149 Salt bridges: A:R.70, A:R.149 BOG.2: 17 residues within 4Å: Chain A: P.191, E.192, L.195, W.197, H.199, Y.200, N.201, L.232, L.236, P.242, L.246, K.249, I.259, L.291, D.292, S.293, D.294 19 PLIP interactions: 19 interactions with chain A Hydrophobic interactions: A:P.191, A:E.192, A:L.195, A:L.232, A:L.236, A:P.242, A:L.246, A:L.246, A:I.259, A:L.291 Hydrogen bonds: A:H.199, A:N.201, A:K.249, A:K.249, A:D.292, A:D.292, A:S.293, A:S.293 Water bridges: A:E.192

1 x F46: N-[2-fluoro-5-({9-[2-(morpholin-4-yl)ethoxy]-11-oxo-6,11-dihydrodibenzo[b,e]oxepin-3-yl}amino)phenyl]benzamide(Non-covalent)

F46.3: 21 residues within 4Å: Chain A: V.30, R.49, A.51, K.53, E.71, L.74, L.75, I.84, L.104, T.106, L.108, M.109, G.110, A.111, D.112, L.167, D.168, F.169, L.171, H.174 Ligands: BOG.1 18 PLIP interactions: 18 interactions with chain A Hydrophobic interactions: A:A.51, A:K.53, A:E.71, A:L.74, A:L.75, A:T.106, A:L.108, A:L.167, A:D.168, A:L.171 Hydrogen bonds: A:R.49, A:K.53, A:E.71, A:M.109, A:G.110, A:D.168, A:F.169, A:F.169

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Baur, B. et al., Metabolically Stable Dibenzo[b,e]oxepin-11(6H)-ones as Highly Selective p38 MAP Kinase Inhibitors: Optimizing Anti-Cytokine Activity in Human Whole Blood. J.Med.Chem. (2013)

Release Date

2013-10-30

Peptides

Mitogen-activated protein kinase 14: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Mitogen-activated protein kinase 14

Related Entries With Identical Sequence